Similar articles

• The action of microelectrophoretically applied (3,4-dihydroxy-phenylamino)-2-imidazoline (DPI) on single cortical neurones.

  Bevan P, Bradshaw CM, Pun RY, Slater NT, Szabadi E. Bevan P, et al. Br J Pharmacol. 1979 Apr;65(4):701-6. doi: 10.1111/j.1476-5381.1979.tb07884.x. Br J Pharmacol. 1979. PMID: 435693 Free PMC article.
• (3,4-Dihydroxy-phenylamino)-2-imidazoline (DPI), a new potent agonist at dopamine receptors mediating neuronal inhibition.

  Struyker Boudier H, Teppema L, Cools A, Van Rossum J. Struyker Boudier H, et al. J Pharm Pharmacol. 1975 Nov;27(11):882-3. doi: 10.1111/j.2042-7158.1975.tb10240.x. J Pharm Pharmacol. 1975. PMID: 1506 No abstract available.
• (3,4-Dihydroxyphenylimino)-2-imidazoline (DPI) and its action at noradrenergic and dopaminergic receptors in the nucleus accumbens of rats: mesolimbic catecholamine receptors and hyperactivity.

  Cools AR, Oosterloo SK. Cools AR, et al. J Neural Transm Suppl. 1983;18:181-8. J Neural Transm Suppl. 1983. PMID: 6308148
• Comparison of the effects of dopamine and noradrenaline on single cortical neurones [proceedings].

  Bevan P, Bradshaw CM, Szabadi E. Bevan P, et al. Br J Pharmacol. 1977 Mar;59(3):468P-469P. Br J Pharmacol. 1977. PMID: 843710 Free PMC article. No abstract available.
• (3,4-Dihydroxyphenylimino)-2-imidazoline (DPI): a stimulant of alpha-adrenoceptors and dopamine receptors.

  Struyker-Boudier HA, Cools AR. Struyker-Boudier HA, et al. J Pharm Pharmacol. 1984 Dec;36(12):859-60. doi: 10.1111/j.2042-7158.1984.tb04897.x. J Pharm Pharmacol. 1984. PMID: 6151987 No abstract available.